Medifast Inc financial data

Symbol
MED on NYSE
Industry
Miscellaneous Food Preparations & Kindred Products
Location
11445 Cronhill Drive, Owings Mills, MD
State of incorporation
DE
Fiscal year end
December 31
Former names
HEALTHRITE INC (to 1/9/2001)
Latest financial report
10-Q - Q2 2024 - Aug 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 251 % +49.5%
Quick Ratio 56 % -29.4%
Debt-to-equity 51.2 % -45.4%
Return On Equity 14.5 % -82%
Return On Assets 9.57 % -76.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10.9M shares +0.44%
Common Stock, Shares, Outstanding 10.9M shares +0.44%
Entity Public Float 1B USD -50%
Common Stock, Value, Issued 11K USD 0%
Weighted Average Number of Shares Outstanding, Basic 10.9M shares +0.45%
Weighted Average Number of Shares Outstanding, Diluted 10.9M shares +0.18%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 390M USD -5.56%
Revenue from Contract with Customer, Excluding Assessed Tax 770M USD -43.9%
Cost of Revenue 201M USD -49.7%
Operating Income (Loss) 34.2M USD -80.2%
Nonoperating Income (Expense) 3.04M USD -775%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 37.3M USD -78.4%
Income Tax Expense (Benefit) 7.96M USD -80%
Net Income (Loss) Attributable to Parent 29.3M USD -77.9%
Earnings Per Share, Basic 2.68 USD/shares -78.1%
Earnings Per Share, Diluted 2.67 USD/shares -78%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 108M USD -26.7%
Cash, Cash Equivalents, and Short-term Investments 165M USD
Inventory, Net 39.6M USD -42.5%
Assets, Current 224M USD -1.97%
Deferred Income Tax Assets, Net 4.11M USD -9.28%
Property, Plant and Equipment, Net 39.9M USD -26.6%
Operating Lease, Right-of-Use Asset 13.4M USD -19.7%
Other Assets, Noncurrent 11.8M USD -17.5%
Assets 294M USD -7.91%
Contract with Customer, Liability, Current 574K USD -92.2%
Liabilities, Current 75.2M USD -34.6%
Operating Lease, Liability, Noncurrent 13.1M USD -28.5%
Liabilities 88.2M USD -33.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 26K USD -78.9%
Retained Earnings (Accumulated Deficit) 175M USD +6.69%
Stockholders' Equity Attributable to Parent 205M USD +10.6%
Liabilities and Equity 294M USD -7.91%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 7.28M USD -88.6%
Net Cash Provided by (Used in) Financing Activities -1.49M USD +94.2%
Net Cash Provided by (Used in) Investing Activities -2.78M USD -31.2%
Common Stock, Shares Authorized 20M shares 0%
Common Stock, Shares, Issued 10.9M shares +0.44%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.03M USD -91.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 108M USD -26.7%
Deferred Tax Assets, Valuation Allowance 1.68M USD -33.4%
Deferred Tax Assets, Gross 20.5M USD -6.55%
Operating Lease, Liability 19.1M USD -19.3%
Payments to Acquire Property, Plant, and Equipment 1.84M USD -13%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 29.2M USD -78%
Lessee, Operating Lease, Liability, to be Paid 19.8M USD -20%
Property, Plant and Equipment, Gross 98.8M USD +1.7%
Operating Lease, Liability, Current 6.03M USD +11.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.78M USD -21.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.46M USD +8.51%
Operating Lease, Weighted Average Discount Rate, Percent 0.02 pure 0%
Deferred Income Tax Expense (Benefit) 112K USD -86%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 727K USD -34.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.55M USD -42.5%
Deferred Tax Assets, Operating Loss Carryforwards 2.88M USD -22.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1.5M shares 0%
Unrecognized Tax Benefits 7.5M USD +24.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.62M USD +2.55%
Operating Lease, Payments 1.56M USD -13.4%
Additional Paid in Capital 30.4M USD +41.1%
Depreciation, Depletion and Amortization 3.26M USD +9.65%
Share-based Payment Arrangement, Expense 9.69M USD +7.31%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%